X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs LUPIN LTD - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE LUPIN LTD CADILA HEALTHCARE/
LUPIN LTD
 
P/E (TTM) x 16.4 41.9 39.2% View Chart
P/BV x 3.7 2.6 142.6% View Chart
Dividend Yield % 1.1 0.6 172.9%  

Financials

 CADILA HEALTHCARE   LUPIN LTD
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
LUPIN LTD
Mar-18
CADILA HEALTHCARE/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs5581,465 38.1%   
Low Rs362727 49.7%   
Sales per share (Unadj.) Rs116.3349.6 33.3%  
Earnings per share (Unadj.) Rs17.95.6 321.5%  
Cash flow per share (Unadj.) Rs23.129.6 78.2%  
Dividends per share (Unadj.) Rs3.505.00 70.0%  
Dividend yield (eoy) %0.80.5 166.9%  
Book value per share (Unadj.) Rs85.4300.3 28.4%  
Shares outstanding (eoy) m1,023.74452.08 226.5%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x4.03.1 126.1%   
Avg P/E ratio x25.7197.2 13.0%  
P/CF ratio (eoy) x19.937.1 53.6%  
Price / Book Value ratio x5.43.6 147.5%  
Dividend payout %19.690.0 21.8%   
Avg Mkt Cap Rs m470,664495,502 95.0%   
No. of employees `00011.817.0 69.4%   
Total wages/salary Rs m18,54528,647 64.7%   
Avg. sales/employee Rs Th10,072.79,273.6 108.6%   
Avg. wages/employee Rs Th1,569.11,681.0 93.3%   
Avg. net profit/employee Rs Th1,547.7147.4 1,049.7%   
INCOME DATA
Net Sales Rs m119,049158,042 75.3%  
Other income Rs m1,1321,504 75.3%   
Total revenues Rs m120,181159,545 75.3%   
Gross profit Rs m28,47531,475 90.5%  
Depreciation Rs m5,38810,859 49.6%   
Interest Rs m9112,044 44.6%   
Profit before tax Rs m23,30820,076 116.1%   
Minority Interest Rs m628-71 -885.8%   
Prior Period Items Rs m035 0.0%   
Extraordinary Inc (Exp) Rs m0-14,644 0.0%   
Tax Rs m5,6442,885 195.7%   
Profit after tax Rs m18,2922,513 728.0%  
Gross profit margin %23.919.9 120.1%  
Effective tax rate %24.214.4 168.5%   
Net profit margin %15.41.6 966.5%  
BALANCE SHEET DATA
Current assets Rs m82,005122,095 67.2%   
Current liabilities Rs m60,72050,956 119.2%   
Net working cap to sales %17.945.0 39.7%  
Current ratio x1.42.4 56.4%  
Inventory Days Days7385 86.5%  
Debtors Days Days98120 82.0%  
Net fixed assets Rs m83,703129,876 64.4%   
Share capital Rs m1,024904 113.2%   
"Free" reserves Rs m86,421134,866 64.1%   
Net worth Rs m87,445135,771 64.4%   
Long term debt Rs m25,55164,245 39.8%   
Total assets Rs m180,653263,054 68.7%  
Interest coverage x26.610.8 245.6%   
Debt to equity ratio x0.30.5 61.8%  
Sales to assets ratio x0.70.6 109.7%   
Return on assets %10.61.7 613.7%  
Return on equity %20.91.9 1,130.3%  
Return on capital %22.03.7 591.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42,68353,141 80.3%   
Fx outflow Rs m11,24219,335 58.1%   
Net fx Rs m31,44133,807 93.0%   
CASH FLOW
From Operations Rs m9,19317,512 52.5%  
From Investments Rs m-9,737-14,073 69.2%  
From Financial Activity Rs m515-14,921 -3.5%  
Net Cashflow Rs m-29-11,482 0.3%  

Share Holding

Indian Promoters % 74.8 46.6 160.5%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 8.3 11.3 73.5%  
FIIs % 5.9 31.9 18.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 10.1 108.9%  
Shareholders   44,069 98,259 44.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   TTK HEALTHCARE  ALEMBIC LTD  WYETH LTD  AJANTA PHARMA  SUVEN LIFE  

Compare CADILA HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Recapitalisation Package for PSBs: The Pros & Cons(Podcast)

Corporate governance issues with certain companies, uncertainty surrounding national elections and global issues like trade wars, Brexit, have taken a toll on the Indian markets.

Related Views on News

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The 4-Point Plan to Accelerate India to a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Feb 12, 2019

Two questions I have been eagerly waiting to ask you ever since Budget 2019 was announced.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Feb 22, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - ASTRAZENECA PHARMA COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS